Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Fresenius Medical Care
(NYSE:FMS)
Intraday
$21.14
-0.34
[-1.58%]
After-Hours
$21.14
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$21.14
-0.34
[-1.58%]
At close: Apr 24
$21.14
0
[0.00%]
PreMarket: 4:05AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Fresenius Medical Care Stock (NYSE:FMS)
Fresenius Medical Care Stock (NYSE: FMS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 22, 2024
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Avi Kapoor
-
1 day ago
Tuesday, March 05, 2024
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Vandana Singh
-
Mar 5, 2024, 3:21PM
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 5, 2024, 1:11PM
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
Mar 5, 2024, 10:56AM
Shares of dialysis stocks are trading higher in reaction to Novo Nordisk's Ozempic kidney disease data.
Benzinga Newsdesk
-
Mar 5, 2024, 10:17AM
Tuesday, February 20, 2024
Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details
Vandana Singh
-
Feb 20, 2024, 1:17PM
Earnings Scheduled For February 20, 2024
Benzinga Insights
-
Feb 20, 2024, 6:52AM
Fresenius Medical Care: Q4 Earnings Insights
Benzinga Insights
-
Feb 20, 2024, 6:00AM
Fresenius Medical Care Expects 2024 Operating Income To Grow By A Mid-To High-Teens Percent Rate Compared To Prior Year
Benzinga Newsdesk
-
Feb 20, 2024, 5:03AM
Fresenius Medical Care Expects 2024 Revenue To Grow By A Low-To Mid-Single Digit Percent Rate Compared To Prior Year
Benzinga Newsdesk
-
Feb 20, 2024, 5:01AM
Fresenius Medical Care Q4 Adjusted EPADS $0.47 Beats $0.32 Estimate, Sales $5.37B Beat $5.35B Estimate
Benzinga Newsdesk
-
Feb 20, 2024, 4:57AM
Monday, February 19, 2024
A Preview Of Fresenius Medical Care's Earnings
Benzinga Insights
-
Feb 19, 2024, 9:01AM
Wednesday, February 14, 2024
Fresenius Medical Care shares are trading higher in sympathy with dialysis peer DaVita, which reported better-than-expected Q4 financial results.
Benzinga Newsdesk
-
Feb 14, 2024, 10:17AM
Thursday, February 08, 2024
The FDA Has Granted 510(K) Clearance To Fresenius Medical Care's 5008X Hemodialysis System; The Clearance Allows The Start Of Clinical Evaluations And User Studies In US, With A Planned Broad Commercial Launch In 2025
Benzinga Newsdesk
-
Feb 8, 2024, 6:37AM
Monday, January 08, 2024
Fresenius Medical Care Executes On Its Strategic Portfolio Optimization Program And Announces Key Transactions
Benzinga Newsdesk
-
Jan 8, 2024, 8:37AM
Wednesday, December 20, 2023
Fresenius Majority-Owned Group Mabxience Has Licensing Agreement With Intas Pharmaceuticals for Autoimmune Disease Drug Etanercept
Charles Gross
-
Dec 20, 2023, 5:02AM
Wednesday, December 06, 2023
Fresenius Medical Care Hit By Major Data Breach: Half A Million Patients Potentially Affected
Nabaparna Bhattacharya
-
Dec 6, 2023, 11:28AM
Friday, November 24, 2023
HSBC Upgrades Fresenius Medical Care to Hold
Benzinga Newsdesk
-
Nov 24, 2023, 5:19AM
Tuesday, November 21, 2023
Fresenius Medical Care Expects Net Positive Impact On Operating Income (Guidance Basis) Of Approx. EUR 175M In Q4
Benzinga Newsdesk
-
Nov 21, 2023, 4:12PM
Fresenius Medical Care Enters Into Favorable Settlement Agreement With US Government; Expects Both Revenue And Operating Income To Be Positively Impacted
Benzinga Newsdesk
-
Nov 21, 2023, 4:09PM
Thursday, October 12, 2023
Fresenius Medical Care Tells Reuters In Statement That Novo Nordisk's Ozempic And Other GLP-1 Drugs May Slow The Progression Of Chronic Kidney Disease, But Overall Mortality Of Treated Individuals Would Also Be Reduced
Benzinga Newsdesk
-
Oct 12, 2023, 12:00PM
Wednesday, October 11, 2023
Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $24
Benzinga Newsdesk
-
Oct 11, 2023, 3:55PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Oct 11, 2023, 1:31PM
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 11, 2023, 1:13PM
Shares of dialysis providers and kidney care stocks are trading lower after Novo Nordisk stopped its semaglutide kidney outcomes trial early based on early signs of efficacy.
Bill Haddad
-
Oct 11, 2023, 11:03AM
What's Going On With Kidney Dialysis Provider Stocks Today?
Vandana Singh
-
Oct 11, 2023, 9:52AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 11, 2023, 9:06AM
Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 11, 2023, 8:24AM
Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
-
Oct 11, 2023, 6:00AM
Tuesday, October 10, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Oct 10, 2023, 5:32PM
Wednesday, October 04, 2023
Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
-
Oct 4, 2023, 6:08AM
Wednesday, August 23, 2023
Fresenius Medical Care Announces FDA Clearance Of Versi HD with GuideMe Software
Benzinga Newsdesk
-
Aug 23, 2023, 9:04AM
Wednesday, August 02, 2023
Fresenius Medical Expects Smaller Annual Income Decline Amid Easing Cost Inflation, Labor Shortages
Vandana Singh
-
Aug 2, 2023, 10:11AM
Earnings Scheduled For August 2, 2023
Benzinga Insights
-
Aug 2, 2023, 8:45AM
Fresenius Medical Care Q2 Adjusted EPADS $0.32 Beats $0.24 Estimate, Sales $5.26B Beat $5.19B Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 3:59AM
Thursday, July 13, 2023
Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $28
Benzinga Newsdesk
-
Jul 13, 2023, 12:48PM
Monday, July 10, 2023
Fresenius Medical Care Appoints Martin Fischer As CFO; Succeeds Helen Giza Effective October 1
Benzinga Newsdesk
-
Jul 10, 2023, 9:03AM
Wednesday, May 10, 2023
Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $26
Benzinga Newsdesk
-
May 10, 2023, 9:20AM
Tuesday, May 09, 2023
Balance Sheet Showdown
GRIT Capital
-
May 9, 2023, 1:25PM
Fresenius Medical Care: Q1 Earnings Insights
Benzinga Insights
-
May 9, 2023, 10:05AM
Thursday, April 13, 2023
Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $24
Benzinga Newsdesk
-
Apr 13, 2023, 9:20AM
Monday, March 13, 2023
A Bullish Sign Appears On Fresenius Medical Care's Chart
Benzinga Insights
-
Mar 13, 2023, 10:49AM
Thursday, February 23, 2023
Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $22
Benzinga Newsdesk
-
Feb 23, 2023, 10:36AM
eBay, Unity Software, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Lisa Levin
-
Feb 23, 2023, 5:53AM
Wednesday, February 22, 2023
Fresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies Structure
Vandana Singh
-
Feb 22, 2023, 10:08AM
Fresenius Medical Care shares are trading higher after the company reported Q4 financial results.
Benzinga Newsdesk
-
Feb 22, 2023, 8:35AM
Earnings Scheduled For February 22, 2023
Benzinga Insights
-
Feb 22, 2023, 5:26AM
Fresenius Medical Care Expects FY23 Revenue To Grow At A Low To Mid-Single-Digit Percentage Rate
Benzinga Newsdesk
-
Feb 22, 2023, 3:55AM
Fresenius Medical Care Q4 Adjusted EPS €0.86 Down From €0.90 YoY, Sales €5.00B Up From €4.65B YoY
Benzinga Newsdesk
-
Feb 22, 2023, 3:52AM
Tuesday, February 21, 2023
Earnings Preview For Fresenius Medical Care
Benzinga Insights
-
Feb 21, 2023, 12:02PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch